Chemoinformaics analysis of 1,2,3,4-Tetramethylcyclohexane
| Molecular Weight | 140.27 | nRot | 0 |
| Heavy Atom Molecular Weight | 120.11 | nRig | 6 |
| Exact Molecular Weight | 140.156 | nRing | 1 |
| Solubility: LogS | -5.067 | nHRing | 0 |
| Solubility: LogP | 4.149 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 30.0359 |
| nHD | 0 | BPOL | 20.0641 |
| QED | 0.484 |
| Synth | 3.376 |
| Natural Product Likeliness | 0.771 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.378 |
| MDCK | 0.0000132 |
| BBB | 0.738 |
| PPB | 0.951952 |
| VDSS | 2.249 |
| FU | 0.0424737 |
| CYP1A2-inh | 0.79 |
| CYP1A2-sub | 0.793 |
| CYP2c19-inh | 0.085 |
| CYP2c19-sub | 0.945 |
| CYP2c9-inh | 0.318 |
| CYP2c9-sub | 0.258 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.439 |
| CYP3a4-inh | 0.27 |
| CYP3a4-sub | 0.597 |
| CL | 15.255 |
| T12 | 0.178 |
| hERG | 0.011 |
| Ames | 0.09 |
| ROA | 0.074 |
| SkinSen | 0.09 |
| Carcinogencity | 0.112 |
| EI | 0.98 |
| Respiratory | 0.169 |
| NR-Aromatase | 0.002 |
| Antiviral | No |
| Prediction | 0.935317 |